NO923508L - Bicykliske karboksylsyrederivater - Google Patents

Bicykliske karboksylsyrederivater

Info

Publication number
NO923508L
NO923508L NO92923508A NO923508A NO923508L NO 923508 L NO923508 L NO 923508L NO 92923508 A NO92923508 A NO 92923508A NO 923508 A NO923508 A NO 923508A NO 923508 L NO923508 L NO 923508L
Authority
NO
Norway
Prior art keywords
cor2
independently
lower alkyl
group
hydroxy
Prior art date
Application number
NO92923508A
Other languages
English (en)
Norwegian (no)
Other versions
NO923508D0 (no
Inventor
Noal Cohen
Ferdinand Kwo-Chen Lee
Keith Alan Yagaloff
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO923508D0 publication Critical patent/NO923508D0/no
Publication of NO923508L publication Critical patent/NO923508L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/46Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
    • C07C57/50Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid containing condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
NO92923508A 1991-09-10 1992-09-09 Bicykliske karboksylsyrederivater NO923508L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75710091A 1991-09-10 1991-09-10
US07/898,852 US5273999A (en) 1991-09-10 1992-06-15 Carboxylic acid leukotriene B4 antagonists

Publications (2)

Publication Number Publication Date
NO923508D0 NO923508D0 (no) 1992-09-09
NO923508L true NO923508L (no) 1993-03-11

Family

ID=27116327

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923508A NO923508L (no) 1991-09-10 1992-09-09 Bicykliske karboksylsyrederivater

Country Status (15)

Country Link
US (2) US5273999A (enExample)
EP (1) EP0531823A1 (enExample)
JP (1) JPH05201915A (enExample)
KR (1) KR930005998A (enExample)
CN (1) CN1071423A (enExample)
AU (1) AU655057B2 (enExample)
CA (1) CA2077213A1 (enExample)
CZ (1) CZ265492A3 (enExample)
FI (1) FI924048L (enExample)
HU (1) HUT66238A (enExample)
IL (1) IL103058A0 (enExample)
NO (1) NO923508L (enExample)
NZ (1) NZ244218A (enExample)
RU (1) RU2067973C1 (enExample)
TW (1) TW218013B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457124A (en) * 1993-12-07 1995-10-10 Hoffmann-La Roche Inc. Carboxylic acid Leukotriene B4 antagonists
US5753702A (en) * 1996-05-22 1998-05-19 University Of Vermont Arachidonic acid metabolite, 16-hete
US6004808A (en) * 1996-06-21 1999-12-21 Aurora Biosciences Corporation Promiscuous G-protein compositions and their use
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
CA2332272A1 (en) 1998-05-15 1999-11-25 University Of Vermont Novel analogs of 16-hydroxyeicosatetraenoic acid
NZ511489A (en) 1998-11-05 2003-08-29 Toyama Chemical Co Ltd A benzene derivative useful as an AP-1 inhibitor
US6019992A (en) * 1998-12-04 2000-02-01 Chesebrough-Pond's Usa Co. Cosmetic skin care compositions containing 4-chromanone
FR2791344B1 (fr) * 1999-03-25 2002-02-15 Adir Nouveaux derives dimeriques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2183126C2 (ru) * 2000-06-26 2002-06-10 Государственное унитарное предприятие "Иммунопрепарат" Средство, нормализующее функциональную активность спинного мозга, и способ его получения
RU2224528C2 (ru) * 2001-07-24 2004-02-27 Брянский государственный университет им. акад. И.Г. Петровского Способ получения биологически активных пептидов каудальной нейросекреторной системы (кнсс) позвоночных
PL206100B1 (pl) * 2001-11-16 2010-06-30 Toyama Chemical Co Ltd Nowe pochodne benzofenonu lub ich sole oraz środek leczniczy
ATE468851T1 (de) * 2002-07-30 2010-06-15 Merck Sharp & Dohme Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
JP4475406B2 (ja) * 2002-07-30 2010-06-09 メルク・シャープ・エンド・ドーム・コーポレイション 異常脂血症および他の脂質障害の治療用のPPARα選択的化合物
US8093253B2 (en) * 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors
EP2943756A4 (en) * 2010-01-13 2016-02-24 Qsc Llc OPTICALLY CONTROLLED MOTORIZED CONTROL DEVICE
US9475749B2 (en) 2013-03-14 2016-10-25 University Of Macau Anti-neurodegenerative natural compound isolated from alpiniae oxyphyllae fructose and their total synthesis
CN105418576B (zh) * 2015-11-16 2018-03-13 北京新沿线医药科技发展有限公司 一种伪麻黄碱类衍生物及其抗过敏应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776944A (en) * 1971-09-16 1973-12-04 Warner Lambert Co Tetraloneoxy acetic acids and esters thereof
DE3275295D1 (en) * 1981-11-12 1987-03-05 Fisons Plc Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them
ZA844519B (en) * 1983-06-24 1985-02-27 Hoffmann La Roche Dihydrobenzopyran derivatives
US4801616A (en) * 1986-03-25 1989-01-31 Eli Lilly And Company Diphenylmethanone compounds and anti-inflammatory use thereof
US4992576A (en) * 1987-01-12 1991-02-12 Eli Lilly And Company Intermediates for leukotriene antagonists
FR2615515B1 (fr) * 1987-05-22 1989-06-30 Adir Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
CA2019335C (en) * 1989-06-27 2000-08-01 Mitoshi Konno Phenylalkan (en)oic acids
US5124350A (en) * 1990-06-28 1992-06-23 G. D. Searle & Co. Leukotriene b4 antagonists

Also Published As

Publication number Publication date
CN1071423A (zh) 1993-04-28
US5434186A (en) 1995-07-18
KR930005998A (ko) 1993-04-20
HU9202817D0 (en) 1992-11-30
FI924048A7 (fi) 1993-03-11
TW218013B (enExample) 1993-12-21
RU2067973C1 (ru) 1996-10-20
EP0531823A1 (en) 1993-03-17
AU655057B2 (en) 1994-12-01
CA2077213A1 (en) 1993-03-11
FI924048L (fi) 1993-03-11
NO923508D0 (no) 1992-09-09
AU2219192A (en) 1993-03-11
NZ244218A (en) 1995-07-26
FI924048A0 (fi) 1992-09-10
CZ265492A3 (en) 1993-03-17
IL103058A0 (en) 1993-02-21
HUT66238A (en) 1994-10-28
JPH05201915A (ja) 1993-08-10
US5273999A (en) 1993-12-28

Similar Documents

Publication Publication Date Title
NO923508L (no) Bicykliske karboksylsyrederivater
EP0971914B1 (en) NEUTRAL COLOURING PHOTOCHROMIC 2H-NAPHTHO 1,2-b PYRANS AND HETEROCYCLIC PYRANS
AR021799A1 (es) Naftopiranos ciclados en c5-6, su preparacion y composiciones y matrices de (co) polimero que las contienen
WO2008114821A1 (ja) 液晶組成物および液晶表示素子
ATE9461T1 (de) Chinonderivate, ihre herstellung und ihre verwendung.
ATE45736T1 (de) Benzofuran- und benzothiophen-derivate, ihre verwendung zur hemmung der leukotrien-biosynthese bei saeugetieren und diese derivate enthaltende pharmazeutische zusammensetzungen.
WO2004022529A3 (en) Diarylurea derivatives and their use as chloride channel blockers
BR0115580A (pt) Derivados de 3-aroilindol e a utilizaçao dos mesmos como agonistas dos receptores cb2
AR005956A1 (es) Derivados de 2-hetaroilciclohexan-1,3-dionas, procedimiento de preparacion de los mismos, compuestos intermediarios de aplicacion exclusiva en dichoprocedimiento, composiciones herbicidas que contienen dichos derivados y procedimiento para controlar el crecimiento de plantas indeseables con
ATE146766T1 (de) Neue glaszusammensetzungen
HU9302327D0 (en) Paf/h1 antagonistic imidazo-pyridines
IE812683L (en) Thieno-pyridine derivatives
JPS5721401A (en) Photopolymerizable composition
MXPA03010321A (es) Derivados de 1-oxa-3,9-diaza-spiro-5,5-undecan-2-onas y su uso como antagonista del receptor de neurocinina.
DE69836808T2 (de) STARK FÄRBENDE PHOTOCHROME 2H-NAPHTHOÄ1,2-bÜ)PYRANE UND HETEROCYCLISCHE PYRANE
GB2093031B (en) 4-aroylimidazol-2-ones
KR20170063922A (ko) 액정 조성물 및 이의 디스플레이 소자
NO944680L (no) Nye tienotiazinerivater, en fremgangsmåte til fremstilling derav samt deres anvendelse
Jayasankar et al. Compositional dependence of optical properties of Pr3+ ions in lithium borate glasses
JPS559015A (en) Coumarin derivative
Torres et al. Two new O-geranyl coumarins from the resinous exudate of Haplopappus multifolius
JPS5714590A (en) 2-benzyl-5-alkyl-tetrahydro-benzo(b)-1,6-naphthyridin-10-one derivative and its preparation
JPS5711970A (en) Quinazolinone compound and its preparation
PT99074A (pt) Processo para a preparacao de 2-(4-piridinil)-1h-pirido{4,3-b}-onas e compostos afins e seus intermediarios e de composicoes farmaceuticas que os contem
Cohen et al. Benzenepropanoic acids containing chromanone or naphthalenone moieties are potent and orally active leukotriene B4 antagonists